Literature DB >> 24755453

Regulation of miR-23b expression and its dual role on ROS production and tumour development.

Massimo Donadelli1, Ilaria Dando1, Claudia Fiorini1, Marta Palmieri2.   

Abstract

Among the wide family of microRNAs, microRNA 23b (miR-23b) intriguingly assumes opposite roles on regulation of reactive oxygen species (ROS) and on the development of human cancers. In this review we describe novel findings concerning the molecular events involved in miR-23b gene activation or repression and in both ROS regulation and tumour development. In particular, we define the molecular targets of miR-23b that determine its function as either a tumour suppressor or oncomir in different cell types. Finally, we analyze the involvement of miR-23b in cancer cell metabolism, including autophagy, and in biomarker signatures of microRNAs allowing a prognostic and therapeutic evaluation in various human cancers.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; MicroRNAs; Reactive oxygen species; Transcriptional regulation; miR-23b

Mesh:

Substances:

Year:  2014        PMID: 24755453     DOI: 10.1016/j.canlet.2014.04.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

1.  LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma.

Authors:  Zoya Najafi; Mohammadreza Sharifi; Gholamreza Javadi
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.

Authors:  Gang Ma; Weijie Dai; Aiyu Sang; Xiaozhong Yang; Chengcheng Gao
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

3.  Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes.

Authors:  V M de Jong; A R van der Slik; S Laban; R van 't Slot; B P C Koeleman; A Zaldumbide; B O Roep
Journal:  Genes Immun       Date:  2016-07-28       Impact factor: 2.676

4.  An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation.

Authors:  Shahnaz Begum; Masamichi Hayashi; Takenori Ogawa; Fayez J Jabboure; Mariana Brait; Evgeny Izumchenko; Sarit Tabak; Steven A Ahrendt; William H Westra; Wayne Koch; David Sidransky; Mohammad O Hoque
Journal:  Sci Rep       Date:  2015-08-28       Impact factor: 4.379

Review 5.  Signaling by exosomal microRNAs in cancer.

Authors:  Germana Falcone; Armando Felsani; Igea D'Agnano
Journal:  J Exp Clin Cancer Res       Date:  2015-04-02

6.  Downregulated microRNA-23b promotes BMP9-mediated osteogenesis in C2C12 myoblast cells by targeting Runx2.

Authors:  Chu Chen; Zuchuan Tang; Qiling Song; Min Yang; Qiong Shi; Yaguang Weng
Journal:  Mol Med Rep       Date:  2016-01-27       Impact factor: 2.952

7.  miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth.

Authors:  M Fulciniti; N Amodio; R L Bandi; A Cagnetta; M K Samur; C Acharya; R Prabhala; P D'Aquila; D Bellizzi; G Passarino; S Adamia; A Neri; Z R Hunter; S P Treon; K C Anderson; P Tassone; N C Munshi
Journal:  Blood Cancer J       Date:  2016-01-15       Impact factor: 11.037

8.  BDE47 induces rat CYP3A1 by targeting the transcriptional regulation of miR-23b.

Authors:  Zhenzhen Sun; Zhan Zhang; Minghui Ji; Hongbao Yang; Meghan Cromie; Jun Gu; Chao Wang; Lu Yang; Yongquan Yu; Weimin Gao; Shou-Lin Wang
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

Review 9.  MicroRNAs Regulate Mitochondrial Function in Cerebral Ischemia-Reperfusion Injury.

Authors:  Yue Hu; Hao Deng; Shixin Xu; Junping Zhang
Journal:  Int J Mol Sci       Date:  2015-10-20       Impact factor: 5.923

10.  A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.

Authors:  Hernando Lopez-Bertoni; Ivan S Kotchetkov; Nicole Mihelson; Bachchu Lal; Yuan Rui; Heather Ames; Maria Lugo-Fagundo; Hugo Guerrero-Cazares; Alfredo Quiñones-Hinojosa; Jordan J Green; John Laterra
Journal:  Cancer Res       Date:  2020-02-24       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.